Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BCAC

Brookline Capital Acquisition (BCAC) Stock Price, News & Analysis

About Brookline Capital Acquisition Stock (NASDAQ:BCAC)

Advanced Chart

Key Stats

Today's Range
$2.61
$3.11
50-Day Range
$0.36
$22.71
52-Week Range
$9.50
$27.74
Volume
29,998 shs
Average Volume
39,682 shs
Market Capitalization
$19.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.

Receive BCAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCAC Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Q2 2023 electroCore, Inc. Earnings Call
LFAC LF Capital Acquisition Corp. II
See More Headlines

BCAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Brookline Capital Acquisition investors own include Advanced Micro Devices (AMD), Meta Platforms (META), Alibaba Group (BABA), Banxa (BNXAF), Crane (CR), Ford Motor (F) and GS Acquisition Holdings Corp II (GSAH).

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:BCAC
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$480 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
5,451,000
Market Cap
$19.90 million
Optionable
Not Optionable
Beta
-0.03
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:BCAC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners